• SAFB, Satellite RNAs, and Heterochromatin Phase Separation

  2026-09-01

  Huo et al. show that the nuclear matrix protein SAFB cooperates with major satellite RNAs to maintain pericentromeric heterochromatin architecture and promote phase separation. Their results connect RNA binding, chromatin condensation, and 3D genome organization, providing a mechanistic framework for studying repeat-rich heterochromatin.

• Epirubicin, B56δ, and Kidney Fibrosis

  2026-08-31

  The 2026 reference study identifies epirubicin as a small-molecule inhibitor of the PP2A regulatory subunit B56δ and links this interaction to reduced renal lipid accumulation and fibrosis. Its combined UUO-mouse and TGF-β-stimulated tubular-cell design supports B56δ as a more selective therapeutic target than the catalytic PP2A subunit, while also highlighting the need for further safety and translational studies.

• SP1/ADAM10/DRP1 Axis in Hypoxic Pulmonary Hypertension

  2026-08-30

  The reference study identifies an SP1-driven ADAM10 signal from hypoxic endothelial cells that promotes smooth muscle cell proliferation and survival through DRP1 and PI3K/AKT/mTOR signaling. Its conditioned-medium and perturbation strategy provides a useful framework for dissecting endothelial–smooth muscle communication and prioritizing mechanistic targets in hypoxia pulmonary hypertension.

• ECE-1c Stability and Cisplatin Resistance in Lung Cancer

  2026-08-29

  Almarza and colleagues show that a non-ubiquitinable ECE-1c variant promotes stemness, cisplatin resistance, and invasiveness in non-small cell lung cancer cells without increasing short-term ET-1 secretion. The study connects ECE-1c stability to CK2-dependent regulation and provides a mechanistic rationale for evaluating silmitasertib in lung cancer models.

• Phenacetin in Human Intestinal Organoid PK Models

  2026-08-29

  Phenacetin can serve as a chemically defined probe for absorption and metabolism studies in human pluripotent stem cell-derived intestinal organoids. This article presents a decision-focused framework linking compound handling, epithelial biology, and assay interpretation.

• Moxidectin–Polyene Synergy in Oral Candidiasis

  2026-08-28

  A 2024 study found that Moxidectin enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis, thereby strengthening polyene–membrane interactions. The work connects transcriptomic, genetic, biochemical, and mouse-model evidence and supports further evaluation of moxidectin as a polyene potentiator rather than as a stand-alone antifungal.

• Self-Amplifying RNA Influenza Vaccines: Dose Sparing

  2026-08-28

  The reference study shows that influenza RNA vaccine performance is strongly subtype- and platform-dependent: sequence-optimized mRNA protected against influenza A at low dose but performed poorly against influenza B, whereas self-amplifying RNA restored robust antibody responses and protection against influenza B. Its head-to-head comparison of modified mRNA, self-amplifying RNA, and circular RNA provides a practical framework for evaluating dose sparing, durability, and translational fidelity in RNA vaccine development.

• Bromodomain Inhibitor (+)-JQ1 Workflows

  2026-08-27

  Translate BET chromatin biology into reproducible workflows for growth, stemness, apoptosis, and combination studies. This guide connects the reference breast-cancer findings with practical dosing, assay design, troubleshooting, and carefully bounded applications in inflammation and BRDT research.

• Lopinavir (ABT-378): HIV Protease Research Guide

  2026-08-27

  Lopinavir, also called ABT-378, is a potent HIV protease inhibitor used in HIV infection research, resistance modeling, and antiviral assay development. Product specifications report picomolar HIV protease inhibition, while a peer-reviewed cell study identified lopinavir as an inhibitor of MERS-CoV replication in the low-micromolar range.

• Recombinant Mouse IFN-γ in MASH-HCC Assays

  2026-08-26

  Use Recombinant Mouse IFN-γ as a controlled antigen-presentation stimulus, antiviral benchmark, or immune-cell activation reagent in MASH-HCC research. This workflow separates cytokine responsiveness from bile acid–driven metabolic suppression, helping researchers identify whether tumor cells remain capable of restoring MHC-I-associated antigenicity.

• Heparin Sodium: Mechanism and Research Workflow

  2026-08-26

  Heparin sodium is a glycosaminoglycan anticoagulant that potentiates antithrombin III and suppresses thrombin and factor Xa. This guide connects its mechanism, formulation, anti-factor Xa activity assay use, aPTT measurement, and research limitations to the supplied product dossier and a plant-nanovesicle study.

• Cefepime (BMY-28142) in Resistance Research

  2026-08-25

  Cefepime can serve as more than a broad-spectrum antibiotic control: it can connect phenotype, resistance-gene mobility, CNS infection research, and neurotoxicity study design. This evidence-led framework helps translational teams build more interpretable bacterial infection models.

• Tyrothricin: Peptide Antibiotic Mixture Guide

  2026-08-25

  Tyrothricin is a peptide antibiotic mixture used to investigate antimicrobial activity and microbial membrane disruption. BA1054 documentation specifies solid storage at -20°C, prompt use after solution preparation, and research-only status.

• Acridine Orange hydrochloride Protocol Guide

  2026-08-24

  Acridine Orange hydrochloride provides a practical dual-fluorescence readout for nucleic-acid staining in cells and organelles, supporting cell cycle analysis, apoptosis detection, and flow cytofluorometric workflows. This dossier-led guide covers preparation, controls, and interpretation limits; it does not define a universal staining concentration or replace orthogonal confirmation of cell state.

• α-Amanitin: From Transcription to eccDNA

  2026-08-23

  α-Amanitin provides a precise perturbation point for connecting RNA polymerase II elongation with enhancer–promoter dynamics, chromatin architecture, and eccDNA biology. This translational framework shows how to move beyond simple transcription assays while keeping causal claims and experimental limitations in view.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page